company background image
SDGC

SundrugLtd OTCPK:SDGC.F Stock Report

Last Price

JP¥22.68

Market Cap

JP¥2.6b

7D

n/a

1Y

-41.1%

Updated

13 May, 2022

Data

Company Financials +
SDGC.F fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance2/6
Financial Health6/6
Dividends5/6

SDGC.F Stock Overview

Sundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan.

SundrugLtd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for SundrugLtd
Historical stock prices
Current Share PriceJP¥22.68
52 Week HighJP¥34.22
52 Week LowJP¥22.68
Beta0.53
1 Month Changen/a
3 Month Changen/a
1 Year Change-41.14%
3 Year Change-13.86%
5 Year Change-31.52%
Change since IPO-0.53%

Recent News & Updates

Shareholder Returns

SDGC.FUS Consumer RetailingUS Market
7Dn/a-0.8%-2.5%
1Y-41.1%11.1%-10.4%

Return vs Industry: SDGC.F underperformed the US Consumer Retailing industry which returned 13.5% over the past year.

Return vs Market: SDGC.F underperformed the US Market which returned -10.8% over the past year.

Price Volatility

Is SDGC.F's price volatile compared to industry and market?
SDGC.F volatility
SDGC.F Average Weekly Movementn/a
Consumer Retailing Industry Average Movement6.7%
Market Average Movement7.8%
10% most volatile stocks in US Market16.6%
10% least volatile stocks in US Market2.8%

Stable Share Price: Insufficient data to determine SDGC.F's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine SDGC.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19575,634Koji Sadakatahttps://www.sundrug.co.jp

Sundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan. It also operates discount stores that offers food, cosmetics, home appliances, clothing, car supplies, sports and goods, alcoholic beverages, and pharmaceutical products, as well as fresh food, kerosene, etc. The company was founded in 1957 and is headquartered in Fuchu, Japan.

SundrugLtd Fundamentals Summary

How do SundrugLtd's earnings and revenue compare to its market cap?
SDGC.F fundamental statistics
Market CapJP¥341.18b
Earnings (TTM)JP¥23.61b
Revenue (TTM)JP¥645.19b

14.5x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SDGC.F income statement (TTM)
RevenueJP¥645.19b
Cost of RevenueJP¥488.32b
Gross ProfitJP¥156.87b
Other ExpensesJP¥133.26b
EarningsJP¥23.61b

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

May 13, 2022

Earnings per share (EPS)201.91
Gross Margin24.31%
Net Profit Margin3.66%
Debt/Equity Ratio0.0%

How did SDGC.F perform over the long term?

See historical performance and comparison

Dividends

2.4%

Current Dividend Yield

35%

Payout Ratio

Valuation

Is SundrugLtd undervalued compared to its fair value and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


40.9%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: SDGC.F ($22.68) is trading below our estimate of fair value ($38.35)

Significantly Below Fair Value: SDGC.F is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: SDGC.F is good value based on its PE Ratio (14.5x) compared to the US Consumer Retailing industry average (18.9x).

PE vs Market: SDGC.F is good value based on its PE Ratio (14.5x) compared to the US market (15.3x).


Price to Earnings Growth Ratio

PEG Ratio: SDGC.F is poor value based on its PEG Ratio (3.1x)


Price to Book Ratio

PB vs Industry: SDGC.F is good value based on its PB Ratio (1.6x) compared to the US Consumer Retailing industry average (2x).


Future Growth

How is SundrugLtd forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

Future Growth Score

1/6

Future Growth Score 1/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


4.6%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SDGC.F's forecast earnings growth (4.6% per year) is above the savings rate (1.9%).

Earnings vs Market: SDGC.F's earnings (4.6% per year) are forecast to grow slower than the US market (12.3% per year).

High Growth Earnings: SDGC.F's earnings are forecast to grow, but not significantly.

Revenue vs Market: SDGC.F's revenue (4.4% per year) is forecast to grow slower than the US market (7.8% per year).

High Growth Revenue: SDGC.F's revenue (4.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: SDGC.F's Return on Equity is forecast to be low in 3 years time (10.8%).


Past Performance

How has SundrugLtd performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


0.7%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: SDGC.F has high quality earnings.

Growing Profit Margin: SDGC.F's current net profit margins (3.7%) are lower than last year (4%).


Past Earnings Growth Analysis

Earnings Trend: SDGC.F's earnings have grown by 0.7% per year over the past 5 years.

Accelerating Growth: SDGC.F's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: SDGC.F had negative earnings growth (-7.1%) over the past year, making it difficult to compare to the Consumer Retailing industry average (1.5%).


Return on Equity

High ROE: SDGC.F's Return on Equity (10.9%) is considered low.


Financial Health

How is SundrugLtd's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: SDGC.F's short term assets (¥201.2B) exceed its short term liabilities (¥97.7B).

Long Term Liabilities: SDGC.F's short term assets (¥201.2B) exceed its long term liabilities (¥8.4B).


Debt to Equity History and Analysis

Debt Level: SDGC.F is debt free.

Reducing Debt: SDGC.F has not had any debt for past 5 years.

Debt Coverage: SDGC.F has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: SDGC.F has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is SundrugLtd current dividend yield, its reliability and sustainability?

Dividend Score

4/6

Dividend Score 4/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


2.40%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: SDGC.F's dividend (2.4%) is higher than the bottom 25% of dividend payers in the US market (1.56%).

High Dividend: SDGC.F's dividend (2.4%) is low compared to the top 25% of dividend payers in the US market (4.08%).


Stability and Growth of Payments

Stable Dividend: SDGC.F's dividends per share have been stable in the past 10 years.

Growing Dividend: SDGC.F's dividend payments have increased over the past 10 years.


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (34.7%), SDGC.F's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonable cash payout ratio (68.3%), SDGC.F's dividend payments are covered by cash flows.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

11.3yrs

Average management tenure


CEO

Koji Sadakata

3.08yrs

Tenure

Koji Sadakata serves as CEO, President & Representative Director at Sundrug Co.,Ltd.


Leadership Team

Experienced Management: SDGC.F's management team is seasoned and experienced (11.3 years average tenure).


Board Members

Experienced Board: SDGC.F's board of directors are considered experienced (9.9 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Sundrug Co.,Ltd.'s employee growth, exchange listings and data sources


Key Information

  • Name: Sundrug Co.,Ltd.
  • Ticker: SDGC.F
  • Exchange: OTCPK
  • Founded: 1957
  • Industry: Drug Retail
  • Sector: Consumer Retailing
  • Implied Market Cap: JP¥341.183b
  • Listing Market Cap: JP¥2.640b
  • Shares outstanding: 116.92m
  • Website: https://www.sundrug.co.jp

Number of Employees


Location

  • Sundrug Co.,Ltd.
  • 1-38-1, Wakamatsucho
  • Fuchu
  • Tokyo
  • 183-0005
  • Japan

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/13 00:00
End of Day Share Price2022/05/13 00:00
Earnings2021/12/31
Annual Earnings2021/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.